Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Ejhaem|February 23, 2023
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cellsMaximilian Kiefer, Lorenz Thurner, Theresa Bock, et al.
Nature Reviews. Drug Discovery|September 30, 2025
In vivo chimeric antigen receptor (CAR)-T cell therapyAdrian Bot, Andrew Scharenberg, Kevin Friedman, et al.
Immunity|February 26, 2011
Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivoChris Oschatz, Coen Maas, Bernd Lecher, et al.
Antioxidants (Basel, Switzerland)|December 24, 2021
Lack of Endothelial α1AMPK Reverses the Vascular Protective Effects of Exercise by Causing eNOS UncouplingThomas Jansen, Miroslava Kvandová, Isabella Schmal, et al.
Hemasphere|July 15, 2021
The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma CellsMoritz Bewarder, Maximilian Kiefer, Helene Will, et al.
Science Translational Medicine|April 10, 2015
Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphomaHeiko Bruns, Maike Büttner, Mario Fabri, et al.
Cancer Research|May 15, 2015
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic LeukemiaJumpei Yamazaki, Jaroslav Jelinek, Yue Lu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 6, 2011
α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulationSwenja Schuhmacher, Marc Foretz, Maike Knorr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Pharmacology|June 14, 2014
In vitro and in vivo characterization of a new organic nitrate hybrid drug covalently bound to pioglitazoneMaike Knorr, Michael Hausding, Amanda Pfeffer, et al.
Pageof 18